It's called the FAME study, and doctors placing stents or conducting bypass surgery are going to be hearing more about it. Dr. William Fearon, an assistant professor of cardiovascular medicine at Stanford University, tells host Bruce Japsen about how patients whose treatment was based on fractional flow reserve were less likely to have a major adverse cardiac event than those who had standard angiography.